Skip to Content

Aclidinium Side Effects

For the Consumer

Applies to aclidinium: inhalation aerosol powder

Along with its needed effects, aclidinium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking aclidinium:

Incidence Not Known

  • Decrease in the frequency of urination
  • decrease in urine volume
  • difficulty in passing urine (dribbling)
  • eye pain and blurred vision
  • painful urination

Some side effects of aclidinium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

Less Common

  • Cough
  • diarrhea
  • pain or tenderness around the eyes and cheekbones
  • sneezing
  • troubled breathing
  • vomiting

Rare

  • Chest pain or discomfort
  • difficulty with moving
  • dilated neck veins
  • dry mouth
  • extreme fatigue
  • fainting
  • flushed, dry skin
  • fruit-like breath odor
  • increased hunger
  • increased thirst
  • loss of consciousness
  • muscle pain or stiffness
  • nausea
  • pain, swelling, or redness in the joints
  • slow or irregular heartbeat
  • stomachache
  • sweating
  • swelling of the face, fingers, feet, or lower legs
  • unexplained weight loss

For Healthcare Professionals

Applies to aclidinium: inhalation powder

Gastrointestinal

Common (1% to 10%): Diarrhea (2.7%), toothache (1.1%), vomiting (1.1%)

Uncommon (0.1% to 1%): Dry mouth, abdominal discomfort, tooth abscess

Postmarketing reports: Nausea, stomatitis[Ref]

Nervous system

Common (1% to 10%): Headache (6.6%)

Uncommon (0.1% to 1%): Dizziness[Ref]

Other

Common (1% to 10%): Fall (1.1%)

Uncommon (0.1% to 1%): Candidiasis[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis (5.5%), cough (3%), sinusitis (1.7%), rhinitis (1.6%)

Uncommon (0.1% to 1%): Dysphonia[Ref]

Cardiovascular

Uncommon (0.1% to 1%): First degree AV block, cardiac failure, cardiorespiratory arrest, palpitations

Postmarketing reports: Tachycardia[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, pruritus[Ref]

Genitourinary

Uncommon (0.1% to 1%): Urinary retention[Ref]

Metabolic

Uncommon (0.1% to 1%): Diabetes mellitus (less than 1%)[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Osteoarthritis (less than 1%)[Ref]

Ocular

Uncommon (0.1% to 1%): Blurred vision[Ref]

Hypersensitivity

Postmarketing reports: Immediate hypersensitivity reactions, including anaphylaxis, angioedema (including swelling of the lips, tongue, or throat), urticaria, rash, bronchospasm, itching[Ref]

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Tudorza Pressair (aclidinium)." Forest Pharmaceuticals, St. Louis, MO.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide